iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for IRMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $90.40 |
| Market Cap | $1.13B |
| P/E Ratio | 47.84 |
| EPS | $1.86 |
| Dividend Yield | 0.20% |
| 52-Week High | $107.90 |
| 52-Week Low | $46.86 |
| Volume | 13 |
| Avg Volume | 0 |
| Revenue (TTM) | $86.28M |
| Net Income | $23.61M |
| Gross Margin | 76.83% |
1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $116.00.